eLife · 2023 · 11 citations · 40 references
Life SciencesNeurosciencePsychiatryGene ExpressionMolecular NeuroscienceNeuropharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapyDepressive DisordersGlutamatergic SignalingCingulate Cortex FunctionGlutamatergic NeurotransmissionMechanisms Of Antidepressant ActionMonoamine SystemsMonoaminergic PathwaysN6-methyladenosine RegulationNeurobiology Of DepressionRapid-acting Antidepressants
Pharmacotherapies for the treatment of major depressive disorder were serendipitously discovered almost seven decades ago. From this discovery, scientists pinpointed the monoaminergic system as the primary target associated with symptom alleviation. As a result, most antidepressants have been engineered to act on the monoaminergic system more selectively, primarily on serotonin, in an effort to increase treatment response and reduce unfavorable side effects. However, slow and inconsistent clinical responses continue to be observed with these available treatments. Recent findings point to the glutamatergic system as a target for rapid acting antidepressants. Investigating different cohorts of depressed individuals treated with serotonergic and other monoaminergic antidepressants, we found that the expression of a small nucleolar RNA, SNORD90 , was elevated following treatment response. When we increased Snord90 levels in the mouse anterior cingulate cortex (ACC), a brain region regulating mood responses, we observed antidepressive-like behaviors. We identified neuregulin 3 ( NRG3 ) as one of the targets of SNORD90 , which we show is regulated through the accumulation of N 6 -methyladenosine modifications leading to YTHDF2-mediated RNA decay. We further demonstrate that a decrease in NRG3 expression resulted in increased glutamatergic release in the mouse ACC. These findings support a molecular link between monoaminergic antidepressant treatment and glutamatergic neurotransmission.
40
Deep Brain Stimulation for Treatment-Resistant Depression
Helen S. Mayberg, Andrés M. Lozano, Valerie Voon et al. · Neuron · 2005 · 4.1K citations · Full text
Antidepressant effects of ketamine in depressed patients
Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations
Medicine, Pharmacology, Psychiatry +14
m6A RNA methylation promotes XIST-mediated transcriptional repression
Deepak P. Patil, Chun‐Kan Chen, Brian F. Pickering et al. · Nature · 2016 · 1.8K citations
A large-scale binding and functional map of human RNA-binding proteins
Eric L. Van Nostrand, Peter Freese, Xiaofeng Wang et al. · Nature · 2020 · 1.4K citations · Full text